|
May 21, 2012
| Editor: Ahmed Enany President & CEO Southern California Biomedical Council enany@socalbio.org www.socalbio.org
|
New SoCalBio Members |
Claremont BioSolutions (Upland)
BioSolutions (ClaremontBio) is dedicated to next-generation devices for lysis and nucleic acid extraction from microbial cells for PCR ready sample. Key focuses on ClaremontBio's novel technology are ease of use, disposibility, cost effectiveness, versatility, elimination of extensive protocols, as well as elimination of the need for additional lab equipment such as centrifuges and wash baths.This novel technology can be applied to point-of-care systems, mini flow through platforms and various other integrations ... Learn more
One3 IP Management (Newbury Park)
One3 IP is dedicated to intellectual property management. The company is represented in SoCalBio by its CEO Peter Weinstein peter_weinstein@one3ip.com
|
|
BioGENEius Competition |
SoCalBio Announces Southern California Nominees to the BioGENEius Challenge Award
SoCalBio is pleased to announce the following Southern California nominees for the BioGENEius Challenge Award:
- Kenneth Lee, a 12th grader at Palos Verdes Peninsula High School (Los Angeles County) whose research project is entitled: "The Role of Testosterone in Hepatocyte Apoptosis in High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease."
- Jiho Park, a 10th grader at University High School (Orange County) whose research project focuses on: "Modeling Molecular Dynamics Simulations of Membrane-Bound Aromatase Reveal Novel Druggable Sites."
The Two SoCalBio nominees -- Mr. Lee and Mr. Park -- were selected by SoCalBio from hundreds of participants representing high schools in various science fairs held in Los Angeles, Orange County, the Inland Empire and Gold Coast communities. Lee and Park will travel to Boston to represent Southern California in the BioGENEius Challenge organized by the Biotechnology Institute in conjunction with the BIO International Convention in Boston (MA) from June 18 to June 21. The International BioGENEius Challenge is the premier competition for high school students that recognizes outstanding research in biotechnology.
Congratulations to the SoCalBio Nominees and We Wish Them the Best of Luck in Boston.
|
Coming in September |

|
Immunotherapy |
Critical Success Factors For The Immunotherapy Race
Southland healthcare blogger Andrew Norris, PhD, discusses four criteria impacting the success of immunotherapeutics including (1) aspects surrounding the technology used to enhance immune response to the drug (the type of adjuvant/delivery system employed), (2) the breadth of antigens targeted by the drug, (3) the targeting of cancer stem cells, and (4) the use of cost-effective technology so as to avoid some of the earlier pitfalls in reimbursement, logistics, and expense of development ...Read blog
|
Drug Approval |
New Study Concludes FDA Outpaced the EMA on Drug Reviews and New Approvals
The New England Journal of Medicine found that FDA regulators were on average 15% faster than either the EMA or Health Canada. Of the 225 drug applications studied, the average review time hit 322 days at the FDA. And the U.S. agency was the first to approve two of every three new drugs filed with both the FDA and the EMA ... Read more
|
Medical Wireless |
FCC to Set Aside Bandwidth for
Wireless Medical Devices
The spectrum will work specifically with MBAN (medical body area network) sensor devices. Similar in size and shape to a Band-Aid, the sensors would be disposable and include a low-power radio transmitter, according to an FCC official ... Read more
|
Device Market |
New Study Expects the Global Medical Device Market to Reach $415 Billion in 2016

The global medical device market is predicted to grow from $322 billion in 2011 to $415 billion in 2016, according to a new report by healthcare market research publisher Kalorama Information ... Read more
|
 |
Click on image for more info
|
|
Nitinol Stents |
NeuroSigma Buys Patents That Advance
Thin-Film Nitinol Stents
NSVascular, a subsidiary of the West Los Angeles-based NeuroSigma, has picked up a portfolio of patents that will help it develop its technology for more easily treating intracranial aneurysms. The technology utilizes an alloy that allows stents to be "deformed," inserted through a catheter, then reformed when exposed to body heat. ... Read more
|
IPOs |
Kythera Biopharma Is the First US Bioscience Company to File for an IPOUnder the JOBS Act
After raising $108 million in venture capital, the Calabasas-based Kythera has filed for an IPO designed to raise about $86 million. The IPO's success will hinge on the company's ability to generate some investor excitement over ATX-101, a late-stage fat-busting therapy ... Read more
|
Expansion |
Allergan Expands in New Jersey
The Irvine, CA-based maker of Botox aims to build a 93,000-square-foot R&D expansion in Bridgewater, NJ, with the help of $14.9 million grant awarded last year from the state's economic-development authority, the New Jersey Star-Ledger reports. The expansion will swell Allergan's ranks by 400 jobs... Read more
|
Jobs Available |
Neumedicines (Pasadena)
Omnica (Irvine)
Xencor (Monrovia)
PBS Biotech (Camarillo)
Allvivo Vascular (Lake Forest)
Second Sight Medical Products (Sylmar)
Bioness (Santa Clarita)
Puma Biotechnology (Los Angeles)
Maven Biotechnologies (Monrovia)
Avita Medical (Northridge)
Agensys (Santa Monica)
Amgen (Thousand Oaks)
- Amgen has 150 job openings in Thousand Oaks in research, marketing, information technology, quality, regulatory affairs and HR. Click here to access list
Spectrum Pharmaceuticals (Irvine)
C3 Jian (Inglewood)
|
|
About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|